Joint research with Nagoya City University on a clinical trial app for functional disorders
First written in FY2022. 2 of 4 entries say "Restated". Latest entry: FY2023.
No other company in this theme has enough history to compare yet.
- FY2023RestatedAnnual report
「The initiative with Nagoya City University, a public university corporation, was selected for AMED's FY2022 Project for Practical Research for Innovative Cancer Control.」
The selection for an AMED program of initiatives including joint research with Nagoya City University continues to be disclosed. - FY2023-Q3RestatedAnnual report
「In joint research with academia and other institutions, new initiatives with Nagoya City University, Yokohama City University, the National Center of Neurology and Psychiatry, and others were selected for programs operated by the Japan Agency for Medical Research and Development (AMED) and the Japan Science and Technology Agency (JST).」
The selection by AMED and JST of initiatives including joint research with Nagoya City University on a clinical trial app for functional disorders continues to be disclosed. - FY2023-Q2AdvancedAnnual report
「New initiatives with Nagoya City University, a public university corporation, and others have been selected for programs operated by the Japan Agency for Medical Research and Development and the Japan Science and Technology Agency.」
The selection by AMED and JST of initiatives including joint research with Nagoya City University was disclosed. - FY2022First statedAnnual report
「A joint research agreement with Nagoya City University, a public university corporation, concerning the development of a clinical trial app for functional disorders」
A joint research agreement with Nagoya City University concerning the development of a clinical trial app for functional disorders was disclosed for the first time.